The Advisory Committee is an esteemed group of industry thought leaders assembled by BIO to shape this event’s conference program by collaboratively identifying topics and speakers that will facilitate engaging and informative discussions. 
 

Henry Chen, JD, Managing Partner, Delos Capital

Kyle Hathaway, PhD, Director of Policy and Government Relations, Asia Pacific, MSD

Apo Huang, PhD, Secretary General, Taiwan Bio Industry Organization

Taro Inaba, Managing Partner, Remiges Ventures

Yuichi Iwaki, MD, PhD, President, Chief Executive Officer, and Fouder, MediciNova

Amy Jackson, Japan Representative, PhRMA

Shinichiro Komoto, Partner, Eight Roads

Ryo Kubota, MD, PhD, Representative Executive Officer, Chairman, President and Chief Executive Officer, Kubota Pharmaceutical Holdings Co., Ltd.

Arlene Morris, Chief Executive Officer, Willow Advisors LLC

Kyle Murphy, Managing Director and Founder, KMG Japan

Masako Nakamura, Head of Asia, Alnylam Pharmaceuticals; President and Representative Director, Alnylam Japan K.K

Paul Neureiter, Executive Director for International Government Affairs, Amgen

Toru Seo, PhD, APAC Lead, Scout & Evaluation, Worldwide Business Development, Pfizer, Inc.

Gurkeerat Singh, PhD, Vice President, Emerging Technology and Innovation, Eli Lilly and Company

Charles Stacey, MD, Chief Executive Officer, Cerecin

Ted Tanaka, Partnering Consultant, Tanaka International LLC

Gil Van Bokkelen, PhD, Chairman and Chief Executive Officer, Athersys